A new molecule, HBI-8000, has shown to reduce the risk of progression of advanced melanoma by 27% and increase the percentage of patients with tumor regression when combined with the standard immunotherapy treatment nivolumab. #Melanoma #Immunoterapia #HDAcinibitori (translated)
www.ilmessaggero.it
Melanoma, scoperta la pillola che ?spoglia? il tumore. «Se individuiamo le cellule maligne possiamo distruggerle»
